We are live on ! Find out more
Caption Management

Caption Management Portfolio holdings

AUM $21.5B Turnover 58.11%
1-Year Est. Return 81.81%
 

Caption Management runs private funds that trade U.S. stocks and stock options, usually holding positions for two to four months. It looks for mispricings in stock and options markets through company research, and aims to profit from moves in share prices or in expected price swings. Jason Strasser and William Cooper, who both graduated from Duke University in 2007, started the firm in 2012 and own most of it. Strasser began his career as an equity derivatives trader at Morgan Stanley and then worked as an analyst at the hedge fund Trafelet & Company. Its funds are open to high net worth individuals, family offices, endowments, foundations and institutional investors.

This Fund
S&P 500
This Quarter Est. Return
+24.89%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
–
AUM
$21.5B
AUM Growth
+$4.34B
Cap. Flow
+$423M
Cap. Flow %
1.97%
Top 10 Hldgs %
19.17%
Holding
2,170
New
686
Increased
353
Reduced
351
Closed
575
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.4 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.42%
2 Technology 5.01%
3 Healthcare 1.9%
4 Consumer Discretionary 1.75%
5 Financials 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ALIT icon
1376
Alight
ALIT
$261M
$390K ﹤0.01%
34,850
-50,000
-59% -$708K
2025 Q1
5 quarters
LFST icon
1377
CALL
Lifestance Health
LFST
$5.04B
$382K ﹤0.01%
+35,700
New +$276K
2026 Q2
0 quarters
RPD icon
1378
Rapid7
RPD
$1B
$377K ﹤0.01%
+46,527
New +$308K
2026 Q2
0 quarters
OLMA icon
1379
CALL
Olema Pharmaceuticals
OLMA
$619M
$375K ﹤0.01%
30,000
-173,100
-85% -$2.32M
2026 Q1
1 quarter
OLMA icon
1380
PUT
Olema Pharmaceuticals
OLMA
$619M
$375K ﹤0.01%
30,000
-46,000
-61% -$616K
2026 Q1
1 quarter
APYX icon
1381
CALL
Apyx Medical
APYX
$110M
$373K ﹤0.01%
83,100
-3,700
-4% -$14.7K
2025 Q3
3 quarters
RRC icon
1382
Range Resources
RRC
$12.7B
$372K ﹤0.01%
10,000
– –
2026 Q1
1 quarter
KOPN icon
1383
Kopin
KOPN
$621M
$367K ﹤0.01%
81,958
+8,909
+12% +$38.8K
2023 Q2
12 quarters
HUCK icon
1384
CALL
Huckleberry.ai, Inc. Class B Common Stock
HUCK
$142M
$367K ﹤0.01%
+117,300
New +$392K
2026 Q2
0 quarters
BWMN icon
1385
Bowman Consulting
BWMN
$712M
$364K ﹤0.01%
+12,477
New +$393K
2026 Q2
0 quarters
TD icon
1386
Toronto Dominion Bank
TD
$204B
$364K ﹤0.01%
+3,000
New +$328K
2026 Q2
0 quarters
PEW.WS icon
1387
GrabAGun Digital Holdings Warrants
PEW.WS
$359K ﹤0.01%
1,196,644
+430,504
+56% +$180K
2025 Q3
3 quarters
XE icon
1388
X-Energy Inc
XE
$2.98B
$356K ﹤0.01%
+19,400
New +$502K
2026 Q2
0 quarters
ALDX icon
1389
Aldeyra Therapeutics
ALDX
$35.2M
$351K ﹤0.01%
165,000
– –
2025 Q4
2 quarters
CELH icon
1390
Celsius Holdings
CELH
$7.58B
$347K ﹤0.01%
11,843
-59,257
-83% -$1.87M
2025 Q1
5 quarters
COUR icon
1391
Coursera
COUR
$1B
$346K ﹤0.01%
61,400
-13,600
-18% -$77.3K
2026 Q1
1 quarter
OCGN icon
1392
CALL
Ocugen
OCGN
$246M
$344K ﹤0.01%
+225,000
New +$342K
2026 Q2
0 quarters
MP icon
1393
MP Materials
MP
$6.83B
$342K ﹤0.01%
6,100
-175,560
-97% -$10.7M
2025 Q4
2 quarters
LZM.WS icon
1394
Lifezone Metals Ltd Warrants
LZM.WS
$5.01M
$336K ﹤0.01%
819,481
+25,000
+3% +$15.6K
2025 Q3
3 quarters
ETSY icon
1395
Etsy
ETSY
$7.97B
$334K ﹤0.01%
4,430
-18,000
-80% -$1.16M
2025 Q1
5 quarters
GENI icon
1396
CALL
Genius Sports
GENI
$1.74B
$333K ﹤0.01%
54,900
-379,100
-87% -$1.96M
2026 Q1
1 quarter
RXRX icon
1397
CALL
Recursion Pharmaceuticals
RXRX
$2.29B
$330K ﹤0.01%
+90,000
New +$300K
2026 Q2
0 quarters
CMTG icon
1398
Claros Mortgage Trust
CMTG
$161M
$329K ﹤0.01%
140,207
-195,555
-58% -$480K
2025 Q1
5 quarters
ASST icon
1399
Strive Inc
ASST
$2.65B
$327K ﹤0.01%
30,000
-3,749
-11% -$55.5K
2026 Q1
1 quarter
EYPT icon
1400
PUT
EyePoint Inc
EYPT
$32.3M
$326K ﹤0.01%
+22,800
New +$305K
2026 Q2
0 quarters

Similar funds

Caption Management's Q2 2026 Portfolio in Review

As of Q2 2026, Caption Management held 2,170 positions worth $21.5B, up 25% from $17.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Caption Management's Q2 2026 filing shows 686 new, 353 increased, 351 reduced and 575 closed positions. Its largest new stake was TSMC: 565,700 shares worth $270M. The largest sale was Meta Platforms (Facebook), an estimated $52.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 88% of assets, down from 89% a quarter earlier, followed by Technology and Healthcare.

  • Caption Management's largest Q2 2026 buy was TSMC: 565,700 shares worth $270M.
  • Caption Management added most to Microsoft in Q2 2026, an estimated $198M increase.
  • Caption Management's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $52.2M.
  • Caption Management fully exited Planet Labs PBC Warrants in Q2 2026, selling an estimated $24.9M.
  • Caption Management's ten largest holdings make up 19% of its $21.5B portfolio in Q2 2026.
  • Caption Management opened 686 new positions and closed 575 in Q2 2026.
  • Caption Management's portfolio value rose 25% quarter-over-quarter to $21.5B.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.